Technical Analysis for RZLT - Rezolute, Inc.

Grade Last Price % Change Price Change
F 6.7 3.88% 0.25
RZLT closed up 3.88 percent on Tuesday, April 13, 2021, on 3.0 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical RZLT trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 3.88%
180 Bearish Setup Bearish Swing Setup 3.88%
Expansion Breakdown Bearish Swing Setup 3.88%
Reversal New Lows Setup Bearish Swing Setup 3.88%
Stochastic Reached Oversold Weakness 3.88%
Outside Day Range Expansion 3.88%
Older End-of-Day Signals for RZLT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 21 hours ago
3x Volume Pace about 23 hours ago
2x Volume Pace about 23 hours ago
1.5x Volume Pace about 23 hours ago
Down 5% about 23 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. Its products include RZ358, a human monoclonal antibody that is in Phase II clinical trial for the treatment of congenital hyperinsulinism, a devastating ultra-orphan pediatric disease; and RZ402, a plasma kallikrein inhibitor, which is in late stage preclinical program for the treatment of diabetic macular edema. It also develops AB101, a human recombinant insulin, which is in Phase I clinical trial for the treatment of patients with type 1 and type 2 diabetes mellitus. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Life Sciences Clinical Medicine Diabetes Monoclonal Antibody Cancer Treatments Insulin Specialty Drugs Metabolic Disease Diabetes Mellitus Diabetic Retinopathy Macular Edema Metabolic Diseases Diabetic Macular Edema Kallikrein Plasma Kallikrein

Is RZLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 33.5
52 Week Low 3.1
Average Volume 9,808
200-Day Moving Average 15.73
50-Day Moving Average 10.19
20-Day Moving Average 7.37
10-Day Moving Average 7.07
Average True Range 0.91
ADX 21.13
+DI 15.27
-DI 20.61
Chandelier Exit (Long, 3 ATRs ) 7.25
Chandelier Exit (Short, 3 ATRs ) 8.82
Upper Bollinger Band 8.38
Lower Bollinger Band 6.35
Percent B (%b) 0.17
BandWidth 27.57
MACD Line -0.93
MACD Signal Line -1.05
MACD Histogram 0.1226
Fundamentals Value
Market Cap 55.96 Million
Num Shares 8.35 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -18.21
Price-to-Sales 0.00
Price-to-Book 38.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.10
Resistance 3 (R3) 8.05 7.54 7.86
Resistance 2 (R2) 7.54 7.18 7.56 7.78
Resistance 1 (R1) 7.12 6.97 7.33 7.17 7.71
Pivot Point 6.61 6.61 6.72 6.63 6.61
Support 1 (S1) 6.19 6.25 6.40 6.24 5.69
Support 2 (S2) 5.68 6.04 5.70 5.62
Support 3 (S3) 5.26 5.68 5.54
Support 4 (S4) 5.31